130 related articles for article (PubMed ID: 26334317)
1. Co-expression of COX-2 and 5-LO in primary glioblastoma is associated with poor prognosis.
Wang X; Chen Y; Zhang S; Zhang L; Liu X; Zhang L; Li X; Chen D
J Neurooncol; 2015 Nov; 125(2):277-85. PubMed ID: 26334317
[TBL] [Abstract][Full Text] [Related]
2. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.
Shono T; Tofilon PJ; Bruner JM; Owolabi O; Lang FF
Cancer Res; 2001 Jun; 61(11):4375-81. PubMed ID: 11389063
[TBL] [Abstract][Full Text] [Related]
4. High Jagged1 expression is associated with poor outcome in primary glioblastoma.
Qiu XX; Wang CH; You N; Chen BJ; Wang XF; Chen YP; Lin ZX
Med Oncol; 2015 Jan; 32(1):341. PubMed ID: 25424769
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 (Cox-2) expression and angiogenesis in glioblastoma.
Onguru O; Gamsizkan M; Ulutin C; Gunhan O
Neuropathology; 2008 Feb; 28(1):29-34. PubMed ID: 18181832
[TBL] [Abstract][Full Text] [Related]
6. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
7. Human cytomegalovirus infection is correlated with enhanced cyclooxygenase-2 and 5-lipoxygenase protein expression in breast cancer.
Costa H; Touma J; Davoudi B; Benard M; Sauer T; Geisler J; Vetvik K; Rahbar A; Söderberg-Naucler C
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2083-2095. PubMed ID: 31203442
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of 5-lipoxygenase in high-grade astrocytomas.
Nathoo N; Prayson RA; Bondar J; Vargo L; Arrigain S; Mascha EJ; Suh JH; Barnett GH; Golubic M
Neurosurgery; 2006 Feb; 58(2):347-54; discussion 347-54. PubMed ID: 16462489
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
Tsidulko AY; Kazanskaya GM; Kostromskaya DV; Aidagulova SV; Kiselev RS; Volkov AM; Kobozev VV; Gaitan AS; Krivoshapkin AL; Grigorieva EV
Tumour Biol; 2017 Sep; 39(9):1010428317724282. PubMed ID: 28945172
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance.
Hara A; Okayasu I
Acta Neuropathol; 2004 Jul; 108(1):43-8. PubMed ID: 15088099
[TBL] [Abstract][Full Text] [Related]
11. Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma.
Gramatzki D; Kickingereder P; Hentschel B; Felsberg J; Herrlinger U; Schackert G; Tonn JC; Westphal M; Sabel M; Schlegel U; Wick W; Pietsch T; Reifenberger G; Loeffler M; Bendszus M; Weller M
Neurology; 2017 Apr; 88(15):1422-1430. PubMed ID: 28298550
[TBL] [Abstract][Full Text] [Related]
12. 5-Lipoxygenase is coexpressed with Cox-2 in sporadic colorectal cancer: a correlation with advanced stage.
Barresi V; Grosso M; Vitarelli E; Tuccari G; Barresi G
Dis Colon Rectum; 2007 Oct; 50(10):1576-84. PubMed ID: 17762961
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of patients with multifocal glioblastoma: a case-control study.
Patil CG; Yi A; Elramsisy A; Hu J; Mukherjee D; Irvin DK; Yu JS; Bannykh SI; Black KL; Nuño M
J Neurosurg; 2012 Oct; 117(4):705-11. PubMed ID: 22920963
[TBL] [Abstract][Full Text] [Related]
14. High delta-like ligand 4 (DLL4) is correlated with peritumoral brain edema and predicts poor prognosis in primary glioblastoma.
Qiu XX; Chen L; Wang CH; Lin ZX; Zhou CF; Liu SY; Wang XF; Chen YP
Medicine (Baltimore); 2014 Aug; 93(8):e57. PubMed ID: 25121357
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors effective on survival of patients with glioblastoma: Anadolu Medical Center experience.
Guden M; Ayata HB; Ceylan C; Kilic A; Engin K
Indian J Cancer; 2016; 53(3):382-386. PubMed ID: 28244465
[TBL] [Abstract][Full Text] [Related]
16. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
17. The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme.
Chambless LB; Kistka HM; Parker SL; Hassam-Malani L; McGirt MJ; Thompson RC
J Neurooncol; 2015 Jan; 121(2):359-64. PubMed ID: 25344883
[TBL] [Abstract][Full Text] [Related]
18. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer.
Tsubochi H; Sato N; Hiyama M; Kaimori M; Endo S; Sohara Y; Imai T
Ann Thorac Surg; 2006 Oct; 82(4):1198-204. PubMed ID: 16996907
[TBL] [Abstract][Full Text] [Related]
19. Prognostic relevance of MAPK expression in glioblastoma multiforme.
Mawrin C; Diete S; Treuheit T; Kropf S; Vorwerk CK; Boltze C; Kirches E; Firsching R; Dietzmann K
Int J Oncol; 2003 Sep; 23(3):641-8. PubMed ID: 12888899
[TBL] [Abstract][Full Text] [Related]
20. The influence of transforming growth factor-α, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer.
Fanelli MF; Chinen LT; Begnami MD; Costa WL; Fregnami JH; Soares FA; Montagnini AL
Histopathology; 2012 Aug; 61(2):153-61. PubMed ID: 22582975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
